Remix Therapeutics
Clinical-stage #biotech company developing novel small molecule therapies designed to reprogram RNA processing and address disease drivers at their origin.
@mpmbioimpact.bsky.social
We are a world-leading biotechnology investment firm with three decades of experience creating and investing in innovative companies seeking to deliver transformative therapies to patients. Find more info at https://mpmbioimpact.com/
@maxbayer.bsky.social
Pharma reporter at Endpoints News | Past: Fierce Biotech and CBS News | mbayer@endpointsnews.com or chat me for Signal. he/him
@helenbranswell.bsky.social
I cover infectious diseases for STAT (www.statnews.com). 2020 Polk winner. Nieman '11. She/her. I write about H5N1 (in all species), Covid, polio, flu, Ebola, RSV, mpox, STIs. Find me on Signal: HBranswell.01
@fullrich.bsky.social
Editor @ Nature‘s Bio team (nature.com @nature.com) - struct bio, RNA, membrane transport, ribosomes, biophysics, proteomics, synth bio, … - located in Berlin. He/him. Opinions are my own.
@nature.com
Research, news, and commentary from Nature, the international science journal. For daily science news, get Nature Briefing: https://go.nature.com/get-Nature-Briefing
@natchembio.nature.com
A scientific journal devoted to publishing the most compelling research, opinion and analysis at the intersection of chemistry and biology.
@daphnezohar.bsky.social
Founder & CEO of www.SeaportTx.com developing new medicines for neuropsychiatric disorders. Co-founder Karuna Tx (KarXt/Cobenfy now at BMS). Founding CEO & Senior Advisor www.puretechhealth.com. Co founder/host @BiotechCH. Board of BIO #Biotech #BioSky
@dannomura.bsky.social
Professor of Chemical Biology and Molecular Therapeutics at UC Berkeley
@science.org
The world's leading outlet for cutting-edge research in all areas of science. https://www.science.org
@samtruex.bsky.social
I value science, medicine, the biotech ecosystem, helping others, mentoring, the outdoors, truth, accountability, family & friends. #BioSky
@jmaraganore.bsky.social
Founding CEO of Alnylam Pharmaceuticals. RNAi therapeutics pioneer. CEO and Principal of JMM Innovations, LLC. Committed to advancing biomedical innovation to patients.
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@dshaywitz.bsky.social
Rangy MD/PhD executive applying AI & digital technologies to biopharma & functional longevity. Player-coach. #Biosky #Medsky Also Timmerman Report, DBMI@HMS, AEI; https://www.astoundinghealthtech.com/
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@carolynbertozzi.bskyverified.social
Baker Family Director, Sarafan ChEM-H, Stanford University and HHMI; EIC of ACS Cent Sci; All views and opinions expressed are my own.
@erictopol.bsky.social
physician-scientist, author, editor https://www.scripps.edu/faculty/topol/ Ground Truths https://erictopol.substack.com SUPER AGERS https://www.simonandschuster.com/books/Super-Agers/Eric-Topol/9781668067666
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. derekb.lowe@gmail.com and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@kylelahucik.bsky.social
reporting on the $, people & startups in the biotech world for Endpoints News | klahucik@endpointsnews.com | also coach high school XC + Track & Field team | askin Qs, joggin 26.2 | 🌎🏳️🌈🏃🏻♂️🗞️💨
@drsam.bsky.social
Pediatric oncologist. Cancer drug developer. Dad joke aficionado. Moth GrandSLAM winner. Climber of mountains. Raconteur. Baker. Orcasonian. Entrepreneur-in-Residence @ GV. I'm also at https://substack.com/@drsamblackman
@scottgottliebmd.bsky.social
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
@jasonmast.bsky.social
Covering science, medicine & business for STAT Reach out on Signal: JasonMast.05
@artkrieg.bsky.social
Love trail running, hiking, Toll-Like receptors 7/8/9, P1 pDC. Founder/CEO of Zola Therapeutics
@peterkolchinsky.bsky.social
Biotech investor. Virologist. Author: The Great American Drug Deal. Founder: No Patient Left Behind. Healthcare reform advocate. Daughter says I’m cool 75% of the time; son says 100%.
@rosslevinemd.bsky.social
Physician Scientist at MSK. All views expressed here are my own & do not represent my employer. COI:http://bit.ly/2LQCLKe
@uwmadisonrna.bsky.social
Interested in science, RNA, splicing, and single molecule biophysics.
@bloodjournals.hematology.org
Portfolio of peer-reviewed journals from ASH including Blood, the most cited peer-reviewed publication in of hematology plus Blood Advances, plus all five Blood specialty journals. Blood Journals - your source for trusted hematology research & reviews.
@patsharp.bsky.social
Drug developer | Co-founder of Gate Bio | Fmr Big Pharma | Inventing small molecule medicines | Artist | Polymath
@oncodaily.bsky.social
Your daily dose of hope, inspiration, and information in the fight against cancer. oncodaily.com
@jespermaag.bsky.social
Associate Director in Bioinformatics and Data Science at Remix Therapeutics. Biotech. Lives in Waltham, Massachusetts. 🇸🇪
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@lifescivc.bsky.social
Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
@johncendpoints.bsky.social
Longtime biotech observer and news guy who created FierceBiotech and founded Endpoints News, which now has more than 200,000 subscribers clustered in the biopharma business. (I also have a thing for agave.)
@bostonglobe.com
New England's leading source for breaking news and analysis. bostonglobe.com
@fda.gov
Yes, it’s really us! Our posts are FDA-approved! Visit us at https://www.fda.gov
@lifesciencecares.bsky.social